Some other tumors, like lymphomas, upregulate PD-L1 via other pathways, including nucleophosmin/anaplastic lymphoma kinase (NPM/ALK), which activates PD-1 expression via the signal transmitter, transcription factor STAT3[33]. Here, NPM1 is linked to lymphoma.